Precision BioSciences Inc (DTIL)

Precision BioSciences experienced six transactions over the past ninety days, totaling 29,500.97 USD in net value. While three insiders purchased shares, officers initiated proposed sales exceeding 100,000 USD. This activity follows a positive earnings report, with the stock price rising 30.5% recently, currently trading near its yearly peak.
Ticker: DTIL Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Precision BioSciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Scimeca Dario Chief Legal Officer Officer
Transaction date
Planned sale
Price
416.71
Quantity 72,013 -16.7%
Value US$4,003,268
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
259.96
Quantity 54,270
Value US$3,834,052
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
302.90
Quantity 82,614
Value US$1,306,035
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
10.26
Quantity 1,000
Value US$100,000
3.0
Frankel Stanley Non-Executive Director
Transaction date
Purchase
Price
6.00
Quantity 1,000 +2.5%
Value US$6,000
3.0
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
6.28
Quantity 2,609 +5.8%
Value US$16,385
3.6
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
6.27
Quantity 1,135 +2.6%
Value US$7,116
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
3.84
Quantity 4,925 -3.9%
Value US$18,912
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
3.84
Quantity 20,559 -7.8%
Value US$78,947
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.84
Quantity 8,149 -6.1%
Value US$31,292
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
3.84
Quantity 4,925 -8.0%
Value US$18,912
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 4,925
Value US$18,929
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 4,925
Value US$18,929
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.84
Quantity 20,559
Value US$79,019
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 8,149
Value US$31,321
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.17
Quantity 34,799
Value US$145,202
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
4.17
Quantity 34,799 -15.1%
Value US$145,112
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
4.03
Quantity 15,213 -12.5%
Value US$61,308
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
4.03
Quantity 10,200 -8.5%
Value US$41,106
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
4.03
Quantity 8,854 -16.5%
Value US$35,682
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 8,854
Value US$35,653
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 10,200
Value US$41,073
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 15,213
Value US$61,260
3.0
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
4.72
Quantity 3,000 +14.4%
Value US$14,160
3.0
Frankel Stanley Non-Executive Director
Transaction date
Purchase
Price
4.70
Quantity 2,700 +16.1%
Value US$12,690
3.6
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.97
Quantity 1,381 +6.3%
Value US$6,864
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
6.49
Quantity 665 -2.3%
Value US$4,316
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
6.49
Quantity 3,409 -2.9%
Value US$22,124
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.49
Quantity 1,303 -1.7%
Value US$8,456
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
6.49
Quantity 1,303
Value US$8,455
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.49
Quantity 3,409
Value US$22,121
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
6.49
Quantity 665
Value US$4,315
3.0
Frankel Stanley Non-Executive Director
Transaction date
Purchase
Price
4.97
Quantity 2,700 +19.2%
Value US$13,419
3.6
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.89
Quantity 1,400 +6.8%
Value US$6,846
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Planned sale
Price
4.26
Quantity 14,827 -16.8%
Value US$63,163
2.1
Kelly John Alexander Officer Officer
Transaction date
Proposed sale
Price
4.26
Quantity 14,827
Value US$63,208
3.5
Buehler Kevin Non-Executive Director
Transaction date
Purchase
Price
4.16
Quantity 5,076 +22.0%
Value US$21,116
3.6
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.14
Quantity 1,682 +8.9%
Value US$6,963
3.6
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.75
Quantity 1,839 +25.5%
Value US$8,735
3.5
Buehler Kevin Non-Executive Director
Transaction date
Purchase
Price
4.67
Quantity 4,523 +51.9%
Value US$21,122
3.0
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
5.30
Quantity 3,250 +41.6%
Value US$17,225
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
5.56
Quantity 964 -0.9%
Value US$5,360
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.56
Quantity 964
Value US$5,355
List Alan Officer Officer
Transaction date
Proposed sale
Price
5.06
Quantity 333
Value US$1,684
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
4.91
Quantity 154 -0.2%
Value US$756
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
4.91
Quantity 272 -1.1%
Value US$1,336
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
4.91
Quantity 154
Value US$756
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
4.91
Quantity 272
Value US$1,336
List Alan Officer Officer
Transaction date
Proposed sale
Price
5.04
Quantity 672
Value US$3,387
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
4.79
Quantity 8,928
Value US$42,727
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
4.79
Quantity 10,287
Value US$49,230
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
4.79
Quantity 8,928 -26.8%
Value US$42,765
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Planned sale
Price
4.79
Quantity 10,287 -10.5%
Value US$49,275
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
4.67
Quantity 36,838 -25.6%
Value US$172,033
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.67
Quantity 36,838
Value US$172,162
3.0
Germano Geno J Non-Executive Director
Transaction date
Purchase
Price
4.49
Quantity 3,605 +85.8%
Value US$16,186
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Purchase
Price
4.75
Quantity 2,113 +5.5%
Value US$10,037
3.5
Buehler Kevin Non-Executive Director
Transaction date
Purchase
Price
4.88
Quantity 4,320 +98.4%
Value US$21,082
3.6
Brown Melinda Non-Executive Director
Transaction date
Purchase
Price
4.55
Quantity 3,016 +71.8%
Value US$13,723
2.1
Kelly John Alexander Chief Financial Officer Officer
Transaction date
Purchase
Price
6.76
Quantity 3,000 +8.6%
Value US$20,280
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Sale
Price
8.19
Quantity 3,012 -9.5%
Value US$24,668
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
8.19
Quantity 588 -6.9%
Value US$4,816
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
8.19
Quantity 588
Value US$4,816
3.4
Amoroso Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.19
Quantity 3,012
Value US$24,669
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
11.79
Quantity 93 -1.4%
Value US$1,096
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Sale
Price
11.79
Quantity 50 -0.1%
Value US$590
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
11.79
Quantity 93
Value US$1,096
2.3
SMITH J. JEFFERSON Officer Officer
Transaction date
Proposed sale
Price
11.79
Quantity 50
Value US$589
List Alan Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.32
Quantity 290 -6.1%
Value US$2,993
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
10.32
Quantity 272 -4.6%
Value US$2,807
Scimeca Dario General Counsel and Secretary Officer
Transaction date
Planned sale
Price
10.32
Quantity 272 -4.6%
Value US$2,807
3.4
Amoroso Michael President and CEO Executive Director
Transaction date
Planned sale
Price
10.32
Quantity 1,526 -10.0%
Value US$15,748
2.3
SMITH J. JEFFERSON Chief Research Officer Officer
Transaction date
Sale
Price
10.32
Quantity 154 -0.2%
Value US$1,589
List Alan Officer Officer
Transaction date
Proposed sale
Price
10.32
Quantity 290
Value US$2,993
Scimeca Dario Officer Officer
Transaction date
Proposed sale
Price
10.32
Quantity 272
Value US$2,807
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-12 2026-11-10 PlS Planned sale

Chief Legal Officer

Officer
72,013 -16.7%
416.71
US$4,003,268
72,013 -16.7% 416.71 US$4,003,268
2026-11-10 2026-11-10 PrS Proposed sale

Officer

Officer
54,270
259.96
US$3,834,052
54,270 259.96 US$3,834,052
2026-11-06 2026-11-06 PrS Proposed sale

Officer

Officer
82,614
302.90
US$1,306,035
82,614 302.90 US$1,306,035
2026-11-05 2026-11-05 PrS Proposed sale

Officer

Officer
1,000
10.26
US$100,000
1,000 10.26 US$100,000
2026-09-30 2026-09-28 B Purchase Non-Executive Director
1,000 +2.5%
6.00
US$6,000
1,000 +2.5% 6.00 US$6,000
2026-09-29 2026-09-25 B Purchase Non-Executive Director
2,609 +5.8%
6.28
US$16,385
2,609 +5.8% 6.28 US$16,385
2026-09-29 2026-09-25 B Purchase Non-Executive Director
1,135 +2.6%
6.27
US$7,116
1,135 +2.6% 6.27 US$7,116
2026-02-19 2026-02-18 PlS Planned sale

Chief Research Officer

Officer
4,925 -3.9%
3.84
US$18,912
4,925 -3.9% 3.84 US$18,912
2026-02-19 2026-02-18 PlS Planned sale

President and CEO

Executive Director
20,559 -7.8%
3.84
US$78,947
20,559 -7.8% 3.84 US$78,947
2026-02-19 2026-02-18 PlS Planned sale

Chief Financial Officer

Officer
8,149 -6.1%
3.84
US$31,292
8,149 -6.1% 3.84 US$31,292
2026-02-19 2026-02-18 PlS Planned sale

General Counsel and Secretary

Officer
4,925 -8.0%
3.84
US$18,912
4,925 -8.0% 3.84 US$18,912
2026-02-18 2026-02-18 PrS Proposed sale

Officer

Officer
4,925
3.84
US$18,929
4,925 3.84 US$18,929
2026-02-18 2026-02-18 PrS Proposed sale

Officer

Officer
4,925
3.84
US$18,929
4,925 3.84 US$18,929
2026-02-18 2026-02-18 PrS Proposed sale

Officer; Director

Executive Director
20,559
3.84
US$79,019
20,559 3.84 US$79,019
2026-02-18 2026-02-18 PrS Proposed sale

Officer

Officer
8,149
3.84
US$31,321
8,149 3.84 US$31,321
2026-01-22 2026-01-22 PrS Proposed sale

Officer; Director

Executive Director
34,799
4.17
US$145,202
34,799 4.17 US$145,202
2026-01-22 2026-01-22 PlS Planned sale

President and CEO

Executive Director
34,799 -15.1%
4.17
US$145,112
34,799 -15.1% 4.17 US$145,112
2026-01-22 2026-01-21 PlS Planned sale

Chief Financial Officer

Officer
15,213 -12.5%
4.03
US$61,308
15,213 -12.5% 4.03 US$61,308
2026-01-22 2026-01-21 PlS Planned sale

Chief Research Officer

Officer
10,200 -8.5%
4.03
US$41,106
10,200 -8.5% 4.03 US$41,106
2026-01-22 2026-01-21 PlS Planned sale

General Counsel and Secretary

Officer
8,854 -16.5%
4.03
US$35,682
8,854 -16.5% 4.03 US$35,682
2026-01-21 2026-01-21 PrS Proposed sale

Officer

Officer
8,854
4.03
US$35,653
8,854 4.03 US$35,653
2026-01-21 2026-01-21 PrS Proposed sale

Officer

Officer
10,200
4.03
US$41,073
10,200 4.03 US$41,073
2026-01-21 2026-01-21 PrS Proposed sale

Officer

Officer
15,213
4.03
US$61,260
15,213 4.03 US$61,260
2025-12-17 2025-12-16 B Purchase Non-Executive Director
3,000 +14.4%
4.72
US$14,160
3,000 +14.4% 4.72 US$14,160
2025-12-17 2025-12-16 B Purchase Non-Executive Director
2,700 +16.1%
4.70
US$12,690
2,700 +16.1% 4.70 US$12,690
2025-12-17 2025-12-15 B Purchase Non-Executive Director
1,381 +6.3%
4.97
US$6,864
1,381 +6.3% 4.97 US$6,864
2025-11-04 2025-11-03 PlS Planned sale

General Counsel and Secretary

Officer
665 -2.3%
6.49
US$4,316
665 -2.3% 6.49 US$4,316
2025-11-04 2025-11-03 PlS Planned sale

President and CEO

Executive Director
3,409 -2.9%
6.49
US$22,124
3,409 -2.9% 6.49 US$22,124
2025-11-04 2025-11-03 PlS Planned sale

Chief Financial Officer

Officer
1,303 -1.7%
6.49
US$8,456
1,303 -1.7% 6.49 US$8,456
2025-11-03 2025-11-03 PrS Proposed sale

Officer

Officer
1,303
6.49
US$8,455
1,303 6.49 US$8,455
2025-11-03 2025-11-03 PrS Proposed sale

Officer; Director

Executive Director
3,409
6.49
US$22,121
3,409 6.49 US$22,121
2025-11-03 2025-11-03 PrS Proposed sale

Officer

Officer
665
6.49
US$4,315
665 6.49 US$4,315
2025-09-30 2025-09-26 B Purchase Non-Executive Director
2,700 +19.2%
4.97
US$13,419
2,700 +19.2% 4.97 US$13,419
2025-09-24 2025-09-22 B Purchase Non-Executive Director
1,400 +6.8%
4.89
US$6,846
1,400 +6.8% 4.89 US$6,846
2025-07-08 2025-07-03 PlS Planned sale

Chief Financial Officer

Officer
14,827 -16.8%
4.26
US$63,163
14,827 -16.8% 4.26 US$63,163
2025-07-03 2025-07-03 PrS Proposed sale

Officer

Officer
14,827
4.26
US$63,208
14,827 4.26 US$63,208
2025-06-27 2025-06-25 B Purchase Non-Executive Director
5,076 +22.0%
4.16
US$21,116
5,076 +22.0% 4.16 US$21,116
2025-06-27 2025-06-25 B Purchase Non-Executive Director
1,682 +8.9%
4.14
US$6,963
1,682 +8.9% 4.14 US$6,963
2025-03-28 2025-03-26 B Purchase Non-Executive Director
1,839 +25.5%
4.75
US$8,735
1,839 +25.5% 4.75 US$8,735
2025-03-28 2025-03-26 B Purchase Non-Executive Director
4,523 +51.9%
4.67
US$21,122
4,523 +51.9% 4.67 US$21,122
2025-03-27 2025-03-25 B Purchase Non-Executive Director
3,250 +41.6%
5.30
US$17,225
3,250 +41.6% 5.30 US$17,225
2025-03-25 2025-03-24 PlS Planned sale

President and CEO

Executive Director
964 -0.9%
5.56
US$5,360
964 -0.9% 5.56 US$5,360
2025-03-24 2025-03-24 PrS Proposed sale

Officer; Director

Executive Director
964
5.56
US$5,355
964 5.56 US$5,355
2025-03-05 2025-03-05 PrS Proposed sale

Officer

Officer
333
5.06
US$1,684
333 5.06 US$1,684
2025-03-05 2025-03-04 PlS Planned sale

Chief Research Officer

Officer
154 -0.2%
4.91
US$756
154 -0.2% 4.91 US$756
2025-03-05 2025-03-04 PlS Planned sale

General Counsel and Secretary

Officer
272 -1.1%
4.91
US$1,336
272 -1.1% 4.91 US$1,336
2025-03-04 2025-03-04 PrS Proposed sale

Officer

Officer
154
4.91
US$756
154 4.91 US$756
2025-03-04 2025-03-04 PrS Proposed sale

Officer

Officer
272
4.91
US$1,336
272 4.91 US$1,336
2025-01-24 2025-01-24 PrS Proposed sale

Officer

Officer
672
5.04
US$3,387
672 5.04 US$3,387
2025-01-22 2025-01-22 PrS Proposed sale

Officer

Officer
8,928
4.79
US$42,727
8,928 4.79 US$42,727
2025-01-22 2025-01-22 PrS Proposed sale

Officer

Officer
10,287
4.79
US$49,230
10,287 4.79 US$49,230
2025-01-22 2025-01-22 PlS Planned sale

General Counsel and Secretary

Officer
8,928 -26.8%
4.79
US$42,765
8,928 -26.8% 4.79 US$42,765
2025-01-22 2025-01-22 PlS Planned sale

Chief Research Officer

Officer
10,287 -10.5%
4.79
US$49,275
10,287 -10.5% 4.79 US$49,275
2025-01-22 2025-01-21 PlS Planned sale

President and CEO

Executive Director
36,838 -25.6%
4.67
US$172,033
36,838 -25.6% 4.67 US$172,033
2025-01-21 2025-01-21 PrS Proposed sale

Officer; Director

Executive Director
36,838
4.67
US$172,162
36,838 4.67 US$172,162
2025-01-02 2024-12-30 B Purchase Non-Executive Director
3,605 +85.8%
4.49
US$16,186
3,605 +85.8% 4.49 US$16,186
2024-12-31 2024-12-27 B Purchase

Chief Financial Officer

Officer
2,113 +5.5%
4.75
US$10,037
2,113 +5.5% 4.75 US$10,037
2024-12-31 2024-12-27 B Purchase Non-Executive Director
4,320 +98.4%
4.88
US$21,082
4,320 +98.4% 4.88 US$21,082
2024-12-30 2024-12-26 B Purchase Non-Executive Director
3,016 +71.8%
4.55
US$13,723
3,016 +71.8% 4.55 US$13,723
2024-11-21 2024-11-21 B Purchase

Chief Financial Officer

Officer
3,000 +8.6%
6.76
US$20,280
3,000 +8.6% 6.76 US$20,280
2024-11-05 2024-11-04 S Sale

President and CEO

Executive Director
3,012 -9.5%
8.19
US$24,668
3,012 -9.5% 8.19 US$24,668
2024-11-05 2024-11-04 PlS Planned sale

General Counsel and Secretary

Officer
588 -6.9%
8.19
US$4,816
588 -6.9% 8.19 US$4,816
2024-11-04 2024-11-04 PrS Proposed sale

Officer

Officer
588
8.19
US$4,816
588 8.19 US$4,816
2024-11-04 2024-11-04 PrS Proposed sale

Officer; Director

Executive Director
3,012
8.19
US$24,669
3,012 8.19 US$24,669
2024-06-11 2024-06-10 PlS Planned sale

General Counsel and Secretary

Officer
93 -1.4%
11.79
US$1,096
93 -1.4% 11.79 US$1,096
2024-06-11 2024-06-10 S Sale

Chief Research Officer

Officer
50 -0.1%
11.79
US$590
50 -0.1% 11.79 US$590
2024-06-10 2024-06-10 PrS Proposed sale

Officer

Officer
93
11.79
US$1,096
93 11.79 US$1,096
2024-06-10 2024-06-10 PrS Proposed sale

Officer

Officer
50
11.79
US$589
50 11.79 US$589
2024-05-03 2024-05-02 PlS Planned sale

Chief Medical Officer

Officer
290 -6.1%
10.32
US$2,993
290 -6.1% 10.32 US$2,993
2024-05-03 2024-05-02 PlS Planned sale

General Counsel and Secretary

Officer
272 -4.6%
10.32
US$2,807
272 -4.6% 10.32 US$2,807
2024-05-03 2024-05-02 PlS Planned sale

General Counsel and Secretary

Officer
272 -4.6%
10.32
US$2,807
272 -4.6% 10.32 US$2,807
2024-05-03 2024-05-02 PlS Planned sale

President and CEO

Executive Director
1,526 -10.0%
10.32
US$15,748
1,526 -10.0% 10.32 US$15,748
2024-05-03 2024-05-02 S Sale

Chief Research Officer

Officer
154 -0.2%
10.32
US$1,589
154 -0.2% 10.32 US$1,589
2024-05-02 2024-05-02 PrS Proposed sale

Officer

Officer
290
10.32
US$2,993
290 10.32 US$2,993
2024-05-02 2024-05-02 PrS Proposed sale

Officer

Officer
272
10.32
US$2,807
272 10.32 US$2,807

See older Precision BioSciences Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Precision BioSciences Inc history with Plus

Billed monthly · Cancel anytime